Eliaçık, E., Işık, A., Aksu, S., Üner, A., Büyükaşık, Y., Sayınalp, N., . . . Haznedaroğlu, İ. C. (2015). Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms. Turk J Haematol.
Chicago ZitierstilEliaçık, Eylem, Ayşe Işık, Salih Aksu, Ayşegül Üner, Yahya Büyükaşık, Nilgün Sayınalp, Hakan Göker, Osman İ Özcebe, und İbrahim C. Haznedaroğlu. "Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms." Turk J Haematol 2015.
MLA ZitierstilEliaçık, Eylem, et al. "Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms." Turk J Haematol 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.